Trial Details
COMPLETEDBasic Information
| Clinical ID | c1297 |
|---|---|
| Identifier | NCT05242458 |
| Trial Title | A Study of Ustekinumab Treatment in Children With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Ustekinumab |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Burlington |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2022-03-21 |
|---|---|
| Primary Completion Date | 2023-05-22 |
| Completion Date | 2023-05-22 |